VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Bisacodyl
CONNELLY, ROSINA
Human Activities
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020 05 15; 11(1):2416.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Biomarkers, Tumor
Cell Line, Tumor
Collagen
Down-Regulation
Drug Resistance, Neoplasm
Extracellular Matrix
Female
Fibronectins
Focal Adhesion Kinase 1
Gene Expression Regulation, Neoplastic
Humans
Hypoxia
Integrins
Mice
Mice, Nude
MicroRNAs
Neoplasm Transplantation
Protein-Lysine 6-Oxidase
Signal Transduction
Triple Negative Breast Neoplasms